Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacy and Therapeutics|September 17, 2013
An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairmentL Peterson, T Marbury, J Marier, et al.
Diabetes Research and Clinical Practice|June 16, 1999
Repaglinide versus glyburide: a one-year comparison trialT Marbury, W C Huang, P Strange, et al.
Biopharmaceutics & Drug Disposition|April 4, 2003
Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGelT Marbury, E Hamill, R Bachand, et al.
Southern Medical Journal|March 1, 1979
Advanced digoxin toxicity in renal failure: treatment with charcoal hemoperfusionT Marbury, J Mahoney, L Juncos, et al.
The American Journal of Cardiology|October 9, 2001
Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitratesT C Fagan, S Buttler, T Marbury, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 6, 2011
Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjectsZ Li, C Tenhoor, T Marbury, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studiesT Littlejohn, R Saini, K Kassler-Taub, et al.
Clinical Therapeutics|August 27, 1999
Pharmacokinetics of sparfloxacin in patients with renal impairmentM B Dorr, R D Johnson, B Jensen, et al.
Journal of Clinical Pharmacology|January 14, 2005
Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal diseaseR Courtney, A Sansone, W Smith, et al.
Pageof 2